ClinicalTrials HQ

Peking University Cancer Hospital

Peking University Cancer Hospital

Beijing, China

21 results ยท Page 1 of 1

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS MutationsRAS Mutation; Solid TumorNot yet recruitingPhase 12026-09-23NCT07836036
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, adenocarcinoma, bronchial neoplasm, bronchogenic carcinoma, carcinoma, epithelial neoplasm, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmActive, not recruitingPhase 22026-07-14NCT02864992
A Clinical Study GK01 Cell Injection in Subjects With Advanced Lung CancerAdvanced Lung CancerNot yet recruitingEarly phase 12026-06-29NCT07673419
A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCTNeoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, arthropathy, connective tissue neoplasm, disease of the tendon, giant cell tumor, muscle tissue disorder, musculoskeletal system disorder, neoplasm, synovitis, tenosynovial giant cell tumorActive, not recruitingPhase 32026-06-26NCT04488822
A Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.Advanced Solid TumorsNot yet recruitingEarly phase 12026-06-25NCT07412665
HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary InvasionDigestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasmActive, not recruitingNot stated2026-06-09NCT07466225
To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid TumorsBiliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, biliary tract disorder, carcinoma, cholangiocarcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, gallbladder disorder, gallbladder neoplasm, gastric neoplasm, hepatocellular carcinoma, liver disorder, neoplasm, stomach disorderRecruitingPhase 12026-05-19NCT07594964
HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract CancerBiliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, biliary tract disorder, neoplasmRecruitingNot applicable2026-05-08NCT07466238
A Long-term Follow-up Study of Subjects Enrolled in Clinical Trials of Cadonilimab (AK104)Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric neoplasm, neoplasm, stomach disorderRecruitingNot stated2026-04-23NCT07547787
A Clinical Study GK01 Injection in Subjects With Advanced Malignant Solid TumorsAdvanced Solid TumorsNot yet recruitingPhase 12026-03-23NCT07482319
JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer SubjectsNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderRecruitingPhase 32025-09-12NCT06079983
HS-IT101 Injection in the Treatment of Advanced MelanomaAdvanced MelanomaEnrolling by invitationPhase 12025-08-14NCT06941818
Evaluating AI and Human Expert Decisions in Colorectal CancerDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorderNot yet recruitingNot stated2025-07-01NCT07045207
A Phase II Study of Dexamethasone, Azacitidine, Pegaspargase and Tislelizumab Plus Radiotherapy for Patients With Stage I/II Extranodal NK/T-cell LymphomaLymphoma, Extranodal NK-T-Cell, Neoplasms by Histologic Type, T-cell non-Hodgkin lymphoma, lymphoma, neoplasmRecruitingPhase 22025-06-03NCT07000617
A Study to Evaluate the Safety and Efficacy of HB0052 in Patients With Advanced Solid TumorsSolid TumorsEnrolling by invitationPhase 1 / Phase 22025-05-28NCT06992687
Intracorporeal Anastomosis Versus Extracorporeal Anastomosis for Left Colon CancerDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, malignant colon neoplasm, neoplasmActive, not recruitingNot applicable2025-05-07NCT04201717
Mts105 for Advanced Hepatocellular CarcinomaDigestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasmRecruitingPhase 12024-12-24NCT06689540
A Study of PM8002 in Combination With Chemotherapy in Patients With SCLCSCLCActive, not recruitingPhase 22024-12-18NCT05879068
PM8002 in the Treatment of Patients With Advanced Solid Tumorscancer, neoplasmRecruitingPhase 1 / Phase 22024-12-05NCT05918445
Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of IPM514 in Patients with Esophageal Squamous Cell CarcinomaDigestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell neoplasmRecruitingEarly phase 12024-11-15NCT06690476
KN046 Plus Regorafenib or Apatinib in MSI-H Digestive System Cancers Resistant to PD-1/PD-L1 BlockadeDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system cancer, neoplasmRecruitingPhase 22023-10-26NCT06099821